Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Biopharma Reports Progress on Topical Antiviral

publication date: Oct 18, 2007
China Biopharma said that its partner, Soonfast Pharmaceutical, completed a trial production run of its topical antiviral. In June, China Biopharma acquired the ex-China rights to the product, which treats herpes simplex virus (HSV) and human papillomavirus (HPV). The product has been approved for use in China, and will launch in November, now that commercial-level manufacturing has begun. More details...

Stock Symbol: (OTCBB: CBPC)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital